APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ibuprofen API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ibuprofen API Market Outlook and Growth Opportunities 2026

30 December 2025193 pages

Choose your research edition.

Industry ResearchIbuprofen API Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Ibuprofen API Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Ibuprofen API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ibuprofen API Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Ibuprofen API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Asia-Pacific is the largest market of Ibuprofen API with a share of over 30%, the other two main markets are North America and Europe. The top 3 global manufacturers are IOLCP, Biocause, Shandong Xinhua Pharmaceutical.

This report provides an overview of the global Ibuprofen API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ibuprofen API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

Read the full market overview

The report also presents Ibuprofen API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ibuprofen API market size, projected growth trends, production technologies, key applications, and end-use industries.

Ibuprofen API Segment by Company

IOLCP

SOLARA

Shandong Xinhua Pharmaceutical

Biocause

BASF

SI Group

Ibuprofen API Segment by Type

USP

EP

Ibuprofen API Segment by Application

Contract Manufacturing Organizations

Pharmaceutical Companies

Others

Ibuprofen API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ibuprofen API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ibuprofen API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ibuprofen API significant trends, drivers, influence factors in global and regions.

6. To analyze Ibuprofen API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ibuprofen API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ibuprofen API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ibuprofen API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ibuprofen API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ibuprofen API industry.

Chapter 3: Detailed analysis of Ibuprofen API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ibuprofen API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ibuprofen API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ibuprofen API Industry Trends Table 2. Ibuprofen API Industry Drivers Table 3. Ibuprofen API Industry Opportunities and Challenges Table 4. Ibuprofen API Industry Restraints Table 5. Global Ibuprofen API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ibuprofen API Revenue Share by Company (2021-2026) Table 7. Global Ibuprofen API Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Ibuprofen API Sales Volume Share by Company (2021-2026) Table 9. Global Ibuprofen API Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Ibuprofen API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ibuprofen API Key Company Manufacturing Base & Headquarters Table 12. Global Ibuprofen API Company, Product Type & Application Table 13. Global Ibuprofen API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ibuprofen API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of USP Table 18. Significant Companies of EP Table 19. Global Ibuprofen API Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Ibuprofen API Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Ibuprofen API Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Ibuprofen API Sales Volume Share by Type (2021-2026) Table 23. Global Ibuprofen API Sales Volume Share by Type (2027-2032) Table 24. Global Ibuprofen API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ibuprofen API Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Ibuprofen API Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Ibuprofen API Sales Value Share by Type (2021-2026) Table 28. Global Ibuprofen API Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Contract Manufacturing Organizations Table 30. Significant Companies of Pharmaceutical Companies Table 31. Significant Companies of Others Table 32. Global Ibuprofen API Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Ibuprofen API Sales Volume by Application (2021-2026) & (Tons) Table 34. Global Ibuprofen API Sales Volume by Application (2027-2032) & (Tons) Table 35. Global Ibuprofen API Sales Volume Share by Application (2021-2026) Table 36. Global Ibuprofen API Sales Volume Share by Application (2027-2032) Table 37. Global Ibuprofen API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Ibuprofen API Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Ibuprofen API Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Ibuprofen API Sales Value Share by Application (2021-2026) Table 41. Global Ibuprofen API Sales Value Share by Application (2027-2032) Table 42. Global Ibuprofen API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Ibuprofen API Sales by Region (2021-2026) & (Tons) Table 44. Global Ibuprofen API Sales Market Share by Region (2021-2026) Table 45. Global Ibuprofen API Sales by Region (2027-2032) & (Tons) Table 46. Global Ibuprofen API Sales Market Share by Region (2027-2032) Table 47. Global Ibuprofen API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Ibuprofen API Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Ibuprofen API Sales Value Share by Region (2021-2026) Table 50. Global Ibuprofen API Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Ibuprofen API Sales Value Share by Region (2027-2032) Table 52. Global Ibuprofen API Market Average Price (US$/Kg) by Region (2021-2026) Table 53. Global Ibuprofen API Market Average Price (US$/Kg) by Region (2027-2032) Table 54. Global Ibuprofen API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Global Ibuprofen API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Ibuprofen API Sales by Country (2021-2026) & (Tons) Table 57. Global Ibuprofen API Sales Market Share by Country (2021-2026) Table 58. Global Ibuprofen API Sales by Country (2027-2032) & (Tons) Table 59. Global Ibuprofen API Sales Market Share by Country (2027-2032) Table 60. Global Ibuprofen API Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Ibuprofen API Sales Value Market Share by Country (2021-2026) Table 62. Global Ibuprofen API Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Ibuprofen API Sales Value Market Share by Country (2027-2032) Table 64. IOLCP Company Information Table 65. IOLCP Business Overview Table 66. IOLCP Ibuprofen API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 67. IOLCP Ibuprofen API Product Portfolio Table 68. IOLCP Recent Development Table 69. SOLARA Company Information Table 70. SOLARA Business Overview Table 71. SOLARA Ibuprofen API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 72. SOLARA Ibuprofen API Product Portfolio Table 73. SOLARA Recent Development Table 74. Shandong Xinhua Pharmaceutical Company Information Table 75. Shandong Xinhua Pharmaceutical Business Overview Table 76. Shandong Xinhua Pharmaceutical Ibuprofen API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 77. Shandong Xinhua Pharmaceutical Ibuprofen API Product Portfolio Table 78. Shandong Xinhua Pharmaceutical Recent Development Table 79. Biocause Company Information Table 80. Biocause Business Overview Table 81. Biocause Ibuprofen API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 82. Biocause Ibuprofen API Product Portfolio Table 83. Biocause Recent Development Table 84. BASF Company Information Table 85. BASF Business Overview Table 86. BASF Ibuprofen API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 87. BASF Ibuprofen API Product Portfolio Table 88. BASF Recent Development Table 89. SI Group Company Information Table 90. SI Group Business Overview Table 91. SI Group Ibuprofen API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 92. SI Group Ibuprofen API Product Portfolio Table 93. SI Group Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Ibuprofen API Distributors List Table 97. Ibuprofen API Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Ibuprofen API Product Image Figure 2. Global Ibuprofen API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ibuprofen API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ibuprofen API Sales (2021-2032) & (Tons) Figure 5. Global Ibuprofen API Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Ibuprofen API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. USP Image Figure 10. EP Image Figure 11. Global Ibuprofen API Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Ibuprofen API Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Ibuprofen API Sales Volume Share by Type (2021-2032) Figure 14. Global Ibuprofen API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ibuprofen API Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ibuprofen API Sales Value Share by Type (2021-2032) Figure 17. Contract Manufacturing Organizations Image Figure 18. Pharmaceutical Companies Image Figure 19. Others Image Figure 20. Global Ibuprofen API Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Ibuprofen API Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Ibuprofen API Sales Volume Share by Application (2021-2032) Figure 23. Global Ibuprofen API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Ibuprofen API Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Ibuprofen API Sales Value Share by Application (2021-2032) Figure 26. Global Ibuprofen API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 27. Global Ibuprofen API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Ibuprofen API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Ibuprofen API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Ibuprofen API Sales Value (2021-2032) & (US$ Million) Figure 31. North America Ibuprofen API Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Ibuprofen API Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Ibuprofen API Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Ibuprofen API Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Ibuprofen API Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Ibuprofen API Sales Value (2021-2032) & (US$ Million) Figure 37. South America Ibuprofen API Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Ibuprofen API Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Ibuprofen API Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Ibuprofen API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Ibuprofen API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Ibuprofen API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Ibuprofen API Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Ibuprofen API Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • USP
  • EP
Applications
  • Contract Manufacturing Organizations
  • Pharmaceutical Companies
  • Others
Companies covered
  • IOLCP
  • SOLARA
  • Shandong Xinhua Pharmaceutical
  • Biocause
  • BASF
  • SI Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ibuprofen API Sales Value (2021-2032)
  4. 1.2.2 Global Ibuprofen API Sales Volume (2021-2032)
  5. 1.2.3 Global Ibuprofen API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ibuprofen API Market Dynamics
  1. 2.1 Ibuprofen API Industry Trends
  2. 2.2 Ibuprofen API Industry Drivers
  3. 2.3 Ibuprofen API Industry Opportunities and Challenges
  4. 2.4 Ibuprofen API Industry Restraints
3 Ibuprofen API Market by Company
  1. 3.1 Global Ibuprofen API Company Revenue Ranking in 2025
  2. 3.2 Global Ibuprofen API Revenue by Company (2021-2026)
  3. 3.3 Global Ibuprofen API Sales Volume by Company (2021-2026)
  4. 3.4 Global Ibuprofen API Average Price by Company (2021-2026)
  5. 3.5 Global Ibuprofen API Company Ranking (2024-2026)
  6. 3.6 Global Ibuprofen API Company Manufacturing Base and Headquarters
  7. 3.7 Global Ibuprofen API Company Product Type and Application
  8. 3.8 Global Ibuprofen API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ibuprofen API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ibuprofen API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ibuprofen API Market by Type
  1. 4.1 Ibuprofen API Type Introduction
  2. 4.1.1 USP
  3. 4.1.2 EP
  4. 4.2 Global Ibuprofen API Sales Volume by Type
  5. 4.2.1 Global Ibuprofen API Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ibuprofen API Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Ibuprofen API Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Ibuprofen API Sales Value by Type
  9. 4.3.1 Global Ibuprofen API Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ibuprofen API Sales Value by Type (2021-2032)
  11. 4.3.3 Global Ibuprofen API Sales Value Share by Type (2021-2032)
5 Ibuprofen API Market by Application
  1. 5.1 Ibuprofen API Application Introduction
  2. 5.1.1 Contract Manufacturing Organizations
  3. 5.1.2 Pharmaceutical Companies
  4. 5.1.3 Others
  5. 5.2 Global Ibuprofen API Sales Volume by Application
  6. 5.2.1 Global Ibuprofen API Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ibuprofen API Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Ibuprofen API Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Ibuprofen API Sales Value by Application
  10. 5.3.1 Global Ibuprofen API Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ibuprofen API Sales Value by Application (2021-2032)
  12. 5.3.3 Global Ibuprofen API Sales Value Share by Application (2021-2032)
6 Ibuprofen API Regional Sales and Value Analysis
  1. 6.1 Global Ibuprofen API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ibuprofen API Sales by Region (2021-2032)
  3. 6.2.1 Global Ibuprofen API Sales by Region: 2021-2026
  4. 6.2.2 Global Ibuprofen API Sales by Region (2027-2032)
  5. 6.3 Global Ibuprofen API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ibuprofen API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ibuprofen API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ibuprofen API Sales Value by Region (2027-2032)
  9. 6.5 Global Ibuprofen API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ibuprofen API Sales Value (2021-2032)
  12. 6.6.2 North America Ibuprofen API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ibuprofen API Sales Value (2021-2032)
  15. 6.7.2 Europe Ibuprofen API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ibuprofen API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ibuprofen API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ibuprofen API Sales Value (2021-2032)
  21. 6.9.2 South America Ibuprofen API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ibuprofen API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ibuprofen API Sales Value Share by Country, 2025 VS 2032
7 Ibuprofen API Country-level Sales and Value Analysis
  1. 7.1 Global Ibuprofen API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ibuprofen API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ibuprofen API Sales by Country (2021-2032)
  4. 7.3.1 Global Ibuprofen API Sales by Country (2021-2026)
  5. 7.3.2 Global Ibuprofen API Sales by Country (2027-2032)
  6. 7.4 Global Ibuprofen API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ibuprofen API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ibuprofen API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ibuprofen API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ibuprofen API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ibuprofen API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ibuprofen API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ibuprofen API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ibuprofen API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ibuprofen API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ibuprofen API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ibuprofen API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ibuprofen API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ibuprofen API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ibuprofen API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ibuprofen API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ibuprofen API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ibuprofen API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ibuprofen API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ibuprofen API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ibuprofen API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ibuprofen API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ibuprofen API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ibuprofen API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ibuprofen API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ibuprofen API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ibuprofen API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ibuprofen API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ibuprofen API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ibuprofen API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ibuprofen API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ibuprofen API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ibuprofen API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ibuprofen API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 IOLCP
  2. 8.1.1 IOLCP Company Information
  3. 8.1.2 IOLCP Business Overview
  4. 8.1.3 IOLCP Ibuprofen API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 IOLCP Ibuprofen API Product Portfolio
  6. 8.1.5 IOLCP Recent Developments
  7. 8.2 SOLARA
  8. 8.2.1 SOLARA Company Information
  9. 8.2.2 SOLARA Business Overview
  10. 8.2.3 SOLARA Ibuprofen API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 SOLARA Ibuprofen API Product Portfolio
  12. 8.2.5 SOLARA Recent Developments
  13. 8.3 Shandong Xinhua Pharmaceutical
  14. 8.3.1 Shandong Xinhua Pharmaceutical Company Information
  15. 8.3.2 Shandong Xinhua Pharmaceutical Business Overview
  16. 8.3.3 Shandong Xinhua Pharmaceutical Ibuprofen API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Xinhua Pharmaceutical Ibuprofen API Product Portfolio
  18. 8.3.5 Shandong Xinhua Pharmaceutical Recent Developments
  19. 8.4 Biocause
  20. 8.4.1 Biocause Company Information
  21. 8.4.2 Biocause Business Overview
  22. 8.4.3 Biocause Ibuprofen API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Biocause Ibuprofen API Product Portfolio
  24. 8.4.5 Biocause Recent Developments
  25. 8.5 BASF
  26. 8.5.1 BASF Company Information
  27. 8.5.2 BASF Business Overview
  28. 8.5.3 BASF Ibuprofen API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BASF Ibuprofen API Product Portfolio
  30. 8.5.5 BASF Recent Developments
  31. 8.6 SI Group
  32. 8.6.1 SI Group Company Information
  33. 8.6.2 SI Group Business Overview
  34. 8.6.3 SI Group Ibuprofen API Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SI Group Ibuprofen API Product Portfolio
  36. 8.6.5 SI Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ibuprofen API Value Chain Analysis
  2. 9.1.1 Ibuprofen API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ibuprofen API Sales Mode & Process
  6. 9.2 Ibuprofen API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ibuprofen API Distributors
  9. 9.2.3 Ibuprofen API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst